An overview of newborn screening

Research output: Contribution to journalReview article

35 Scopus citations

Abstract

This review of newborn screening examines the beginning of screening with the story of phenylketonuria and explores the principles of screening and the criteria with which disorders were added to newborn screening panels. The explosion of tests that are screened for followed the adoption of tandem mass spectrometry (MS-MS) technology. The inequity of state newborn screening panels was brought to the forefront with an American Academy of Pediatrics task force report in 2000 that called for a national panel. The American College of Medical Genetics convened an expert panel to produce such a panel. In 2006, they published their panel of disorders, recommending a panel of 29 core disorders and 25 additional secondary targets. Ethical arguments about newborn screening have resurfaced with the recent expansion of testing that include arguments about consent, mandatory participation, benefits to those screened, and cost-both to the individual and society. Finally, the future direction of screening is discussed. Newborn screening is undergoing rapid expansion. The addition of tests involves ethical, financial, and social pressures.

Original languageEnglish (US)
Pages (from-to)622-631
Number of pages10
JournalJournal of Developmental and Behavioral Pediatrics
Volume31
Issue number7
DOIs
Publication statusPublished - Sep 1 2010

    Fingerprint

Keywords

  • core panel
  • inherited metabolic disorders
  • newborn screening
  • tandem mass spectrometry

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Developmental and Educational Psychology
  • Psychiatry and Mental health

Cite this